Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
SMI 10'391 -0.8%  SPI 13'317 -0.7%  Dow 29'927 -1.2%  DAX 12'471 -0.4%  Euro 0.9694 -0.2%  EStoxx50 3'433 -0.4%  Gold 1'711 -0.3%  Bitcoin 19'754 -0.2%  Dollar 0.9899 0.7%  Öl 94.9 1.1% 

Aktionärsstruktur

Inhaber in %
Freefloat 99.15
Fidelity Funds SICAV - Global Demographics Fund 73.78
Fidelity Funds SICAV - America Fund 16.13
Fidelity Funds SICAV - World Fund 10.84
The Vanguard Group, Inc. 8.52
Vanguard Group, Inc. (Subfiler) 8.31
Capital Research & Management Co. (Global Investors) 4.57
State Street Corp. 4.21
Vanguard Total Stock Market Index Fund 2.97
Capital Research & Management Co. (International Investors) 2.88
BlackRock Fund Advisors 2.78
Vanguard 500 Index Fund 2.25
BlackRock Institutional Trust Co. NA 2.13
Geode Capital Management LLC 1.68
Massachusetts Financial Services Co. 1.45

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2017 2018 2019 2020 2021
Personal am Ende des Jahres 99'000 103'000 107'000 109'000 113'000
Umsatz pro Mitarbeiter in Mio. EUR 0.28 0.30 0.30 0.32 0.38

Bilanz (in Mio. EUR) - Aktiva

2017 2018 2019 2020 2021
Summe Umlaufvermögen 20'147 14'632 15'667 20'441 24'239
Summe Anlagevermögen 58'821 50'090 50'187 52'674 55'053
Summe Aktiva 76'250 67'173 67'887 72'548 75'196

Bilanz (in Mio. EUR) - Passiva

2017 2018 2019 2020 2021
Gesamtverschuldung/ -verbindlichkeiten 27'924 19'566 19'099 19'890 19'251
Summe Fremdkapital 45'152 36'451 36'586 39'545 39'172
Summe Eigenkapital 31'098 30'722 31'301 33'003 36'024
Summe Passiva 76'250 67'173 67'887 72'548 75'196

Adresse

100 Abbott Park Road, 60064-6400 Abbott Park
Telefon +1 (224) 667-6100
URL http://www.abbott.com

Management

Andrea F. Wainer
Executive VP-Rapid & Molecular Diagnostics
Claire L. Babineaux-Fontenot
Director
Daniel Gesua Sive Salvadori
Executive Vice President-Nutritional Products
Daniel J. Starks
Independent Director
Darren W. McDew
Independent Director
David P. Mark
Vice President-Internal Audit
Gene Huang
Chief Economist & Vice President
Glenn Fletcher Tilton
Independent Director
Hubert L. Allen
Secretary, Executive VP & General Counsel
Jim Leffelman
Manager-Expense Reporting
John G. Stratton
Independent Director
John M. Capek
Executive Vice President-Ventures
Karen Chayavirabood
Regional Director-Asia
Karen Peterson
Treasurer & Vice President
Kathryn S. Collins
Vice President-Commercial Legal Operations
Lisa D. Earnhardt
Executive Vice President-Medical Devices
Mary K. Moreland
Executive Vice President-Human Resources
Melissa Brotz
Vice President-Global Marketing & External Affairs
Michael F. Roman
Independent Director
Michelle A. Kumbier
Independent Director
Nancy McKinstry
Independent Director
Paola Gonzalez
Independent Director
Philip P. Boudreau
Vice President-Finance & Controller
Randel William Woodgrift
Vice President-Global Operations & Cardiovascular
Robert B. Ford
Chairman, President, Chief Executive Officer & COO
Robert Emmett Funck
Chief Financial Officer & Executive VP-Finance
Robert J. Alpern
Independent Director
Sabina Ewing
Chief Investment Officer, VP-Business & Technology
Sally E. Blount
Independent Director
Scott J. House
Senior Vice President-Regulatory Services
Scott Leinenweber
Vice President-Investor Relations
William A. Osborn
Lead Independent Director

Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen